Efficacy and Safety Study of Ticagrelor
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 180 participants.
Also called NCT01812330
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 180 participants
- Registry
-
NCT01812330
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT01812330. Randomized; single masking; primary purpose treatment. Start 2013-01 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety Study of Ticagrelor
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Clopidogrel
- Intervention (Drug)
- Ticagrelor
- Lead sponsor
- General Hospital of Chinese Armed Police Forces
Record details
- Record id
cardio:ct-nct01812330- Content hash
65296e42a575242f81103ddc310e8b80bfbe06982c39a9fd3302e5d541538581